Accessbio
Access Bio’s mission is to improve the lives and well-being of people around the world through the development of in vitro diagnostics technology. They are a trusted partner to international public health agencies and organizations, focusing on the diagnosis and prevention of infectious diseases, including malaria, HIV, HPV, and COVID-19. The company emphasizes innovation, quality control, and global health impact, with a vision to be a global pioneer in in vitro diagnostic technologies and to promote health and well-being through accurate disease diagnosis.
Industries
Nr. of Employees
small (1-50)
Accessbio
Somerset, New Jersey, United States, North America
Products
At-home lateral-flow COVID-19 antigen test (anterior nasal)
A lateral-flow immunoassay kit for qualitative detection of SARS-CoV-2 nucleocapsid antigen using self-collected anterior nasal swabs, intended for non-prescription home use with mobile app interpretation support.
Point-of-care lateral-flow COVID-19 antigen test
A lateral-flow immunoassay intended for point-of-care use to detect SARS-CoV-2 antigens from nasopharyngeal specimens with rapid visual readout.
RT-PCR molecular diagnostic kits
Real-time PCR and RT-PCR kits for laboratory molecular detection and genotyping of viral pathogens (examples include kits for Zika, Dengue, HPV, scrub typhus).
Serology lateral-flow IgM/IgG test (fingerstick)
Rapid serology lateral-flow assay that differentiates IgM and IgG antibodies from small-volume whole blood, serum or plasma with a 10-minute readout.
Malaria and other infectious-disease rapid diagnostic tests (RDTs)
Rapid diagnostic tests for malaria and other infectious diseases designed for use in field and low-resource settings.
POC analyzer and assay cartridges
Small analyzer devices and single-use cartridges for biochemical and immunoassay measurements such as A1c, CRP, and ACR.
At-home lateral-flow COVID-19 antigen test (anterior nasal)
A lateral-flow immunoassay kit for qualitative detection of SARS-CoV-2 nucleocapsid antigen using self-collected anterior nasal swabs, intended for non-prescription home use with mobile app interpretation support.
Point-of-care lateral-flow COVID-19 antigen test
A lateral-flow immunoassay intended for point-of-care use to detect SARS-CoV-2 antigens from nasopharyngeal specimens with rapid visual readout.
RT-PCR molecular diagnostic kits
Real-time PCR and RT-PCR kits for laboratory molecular detection and genotyping of viral pathogens (examples include kits for Zika, Dengue, HPV, scrub typhus).
Serology lateral-flow IgM/IgG test (fingerstick)
Rapid serology lateral-flow assay that differentiates IgM and IgG antibodies from small-volume whole blood, serum or plasma with a 10-minute readout.
Malaria and other infectious-disease rapid diagnostic tests (RDTs)
Rapid diagnostic tests for malaria and other infectious diseases designed for use in field and low-resource settings.
POC analyzer and assay cartridges
Small analyzer devices and single-use cartridges for biochemical and immunoassay measurements such as A1c, CRP, and ACR.
Services
Commercial distribution and channel partnerships
Establishment and management of national and international distribution agreements and channel partnerships to commercialize diagnostic products.
Regulatory documentation and EUA support
Preparation and provision of regulatory documentation packages, instructions for use, and EUA-related materials for diagnostic products.
Commercial distribution and channel partnerships
Establishment and management of national and international distribution agreements and channel partnerships to commercialize diagnostic products.
Regulatory documentation and EUA support
Preparation and provision of regulatory documentation packages, instructions for use, and EUA-related materials for diagnostic products.
Expertise Areas
- Rapid diagnostic test development
- Molecular diagnostics (RT-PCR) development
- Point-of-care and at-home diagnostics
- Analyzer and cartridge-based platform development
Key Technologies
- Lateral-flow immunoassays
- RT-PCR / real-time PCR
- Biosensor-based assays
- Cartridge-based analyzer platforms